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OBJECTIVES We studied the triggering mechanism for neurally mediated syncope.
BACKGROUND Although increased transient sympathetic tone is thought to be necessary for the development
of neurally mediated syncope, little is known about the triggering mechanism for neurally
mediated syncope.
METHODS Plasma epinephrine (EP) and norepinephrine (NE) levels were assessed in 20 syncope
patients during tilt test (80°, 15 min) with and without isoproterenol (ISP, 0.01, 0.02
mg/kg/min). If syncope occurred, propranolol (0.1 mg/kg) was injected.
RESULTS Eight patients experienced syncope during tilting alone, and 9 patients required ISP for
syncope. In the negative response without ISP, NE showed a small statistical 1.7-fold increase
at end of tilting and EP did not change during tilting. When syncope occurred during tilting
alone, a significant 11.7-fold increase in EP at syncope was registered concomitant with a
small 2.5-fold increase in NE. When patients experienced syncope during tilting with ISP,
a significant 5.0-fold increase in EP at syncope was registered concomitant with a small
1.7-fold increase in NE. In patients without ISP, propranolol did not interrupt syncope. In
patients with ISP, six of eight receiving propranolol responded to tilting negatively.
CONCLUSIONS An increase of NE levels may result in inhibition of syncope and an EP surge may be a
triggering mechanism for neurally mediated syncope. Comparatively low levels of EP may be
enough to induce syncope during tilting with ISP compared with tilting alone. Propranolol
is not effective in patients without ISP, but it frequently inhibits syncope in patients with ISP.
Propranolol (0.1 mg/kg) may be insufficient to block the actions of high levels of circulating
EP. (J Am Coll Cardiol 1999;33:350–7) © 1999 by the American College of Cardiology
The head-up tilt test (HUT) is recognized to stimulate
neurally mediated syncope (NMS). Studies in patients with
inducible NMS have shown an increase in heart rate (HR)
before NMS, a finding suggestive of a transient increase in
sympathetic tone (1). The increased transient sympathetic
tone is thought to be necessary for development of NMS
(2,3). Although there are a large number of reports regard-
ing the neurophysiology and hemodynamics of NMS, little
is known about the triggering mechanism for NMS.
The sympathoneural and adrenomedullary hormonal sys-
tems play key roles in the various expressions of cardiovas-
cular stress response. Norepinephrine (NE) is the neuro-
transmitter of the sympathoneural system, and epinephrine
(EP) is the main hormone of the adrenomedullary system.
Plasma NE and EP levels have been used as indications of
activity of these respective systems (4). These cat-
echolamines (CAs) circulate for 1 to 3 min, maintaining a
slightly prolonged sympathoexcitatory effect (5). A dissoci-
ation has been shown between sympathoneural and adre-
nomedullary CA release (6). To evaluate the role of the CAs
in the development of NMS, we assayed the plasma
concentrations of EP and NE during HUT with and
without isoproterenol (ISP) provocation. Although
b-adrenergic blocking drugs are effective in abolishing
NMS during HUT with ISP provocation, the efficacy for
patients who do not require ISP to induce NMS is not high
(7). Thus, we also analyzed the plasma concentration of
CAs after administration of propranolol (PROP) to deter-
mine the reason for this.
METHODS
Patients. We examined 20 consecutive patients with recur-
rent presyncope, syncope or both. The cause of the presyn-
cope and syncope in each patient remained unexplained
despite obtaining complete medical history and thorough
physical examination. None of the patients had any indica-
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tion of organic heart disease or used medication. Written
informed consent was obtained from all patients.
Preparation. To obtain blood pressure (BP) and blood
samples, a cannula (21-gauge) was inserted into the right
brachial artery .30 min before the study, and heparinized
saline solution (concentration, 10 U/ml) was infused
(3 ml/h). A transducer for BP was fastened and calibrated in
the midaxillary line over the fourth intercostal space with
the patient in the supine position. Another cannula was
placed in the left antecubital vein and saline solution was
infused (60 ml/h). ISP solution (concentration, 2.0 mg/ml)
was also given via this cannula, when necessary.
HUT. HUT was performed using a tilt table with a foot
board. Each patient was tilted to an angle of 80° from
horizontal until positive response or for a maximum of
15 min. A positive response was defined as syncope or
presyncope associated with marked hypotension. If there
was no positive response during this 15-min HUT, ISP
infusion was started at 0.01 mg/kg/min and then HUT was
repeated. If the result was again negative, ISP was increased
to 0.02 mg/kg/min, and HUT was repeated again. There
was an interval of 10 to 15 min between each HUT. Surface
electrocardiogram (ECG) and BP were monitored and
recorded at a paper speed of 25 mm/s. Hemodynamic data
were obtained as the average measurement of 5-s periods.
Study design. The study design is shown in Figure 1. The
protocol consisted of three steps to both eliminate unnec-
essary blood samples and evaluate the response to PROP,
since the reproducibility of positive HUT on the same day
has been reported to be high (8,9). If a positive response
occurred in the initial step, the second step was initiated. In
the second step, HUT was performed again after an
injection of saline solution (10 ml) under identical condi-
tions. In the third step, patients received an injection of
PROP (0.1 mg/kg). Ten minutes after this injection, the
patient was rechallenged with HUT under identical condi-
tions.
Blood sampling. When the BP monitoring was judged to
be more important than blood sampling, it was given
priority, because the same cannula was used for both. The
blood sample was immediately stored in ice water, and the
plasma was separated by centrifugation. The plasma con-
centrations of EP and NE were measured by an automated
high-performance liquid chromatography analyzer (Tosho
Co, Tokyo, Japan) (10). In the initial step, the blood
samples were obtained during HUT alone. We sampled
blood at 3 min prior to upright posture (baseline) and every
5 min during upright posture. In the second step, the first
blood collection during upright posture was started at 5 min
before the time when the positive response occurred during
the initial step, and then at every minute and at positive
response or at the end of the 15-min tilting, in addition to
the baseline sample. In the third step, blood was sampled at
baseline (pre-PROP and post-PROP) and at positive re-
sponse or at the end of the 15-min tilting.
Data analysis. Data are presented as mean 6 SD. For the
purposes of analysis, we classified the patients into two
groups, an ISP-independent group and an ISP-dependent
group, according to the need for ISP to induce a positive
HUT response. The mean rate of increase in CAs for each
group was calculated as (mean postvalue)/(mean prevalue)
5 mean rate of increase (reported as a multiple of the mean
prevalue). The differences within the groups were analyzed
by repeated-measures analysis of variance followed by
Scheffe´ F test, and the differences between the two groups
were analyzed by nonparametric Mann-Whitney U test and
chi-square analysis. A p value of ,0.05 was considered
statistically significant.
RESULTS
Outcome of the initial step. In the initial step, eight
patients had a positive response during HUT alone (ISP-
independent group) and nine patients required ISP for a
Abbreviations and Acronyms
BP 5 blood pressure
CA 5 catecholamine
ECG 5 electrocardiogram
EP 5 epinephrine
HR 5 heart rate
HUT 5 head-up tilt test
ISP 5 isoproterenol
NE 5 norepinephrine
NMS 5 neurally mediated syncope
PROP 5 propranolol
Figure 1. Study design. This study consisted of three steps. If a
positive response occurred in the initial step, the protocol turned to
second step immediately. In the second step, HUT was performed
again under identical conditions. In the third step, the patient was
rechallenged with HUT after an injection of PROP.
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positive response (ISP-dependent group); the remaining
three patients did not develop NMS despite ISP provoca-
tion. The patients in the ISP-independent group tended to
be younger than the patients in the ISP-dependent group
(28.3 6 10.2 years old vs. 45.2 6 13.6 years old, respec-
tively, p 5 0.05, Table 1).
HEMODYNAMICS. Control (without ISP) supine BP and HR
tended to be lower in the ISP-independent group than in
the ISP-dependent group: systolic BP, 122.4 6 10.1 versus
131.9 6 8.6 mm Hg (p 5 0.05); diastolic BP, 66.8 6 8.3
versus 73.9 6 7.0 mm Hg (p 5 0.07); HR, 67.3 6 7.8
versus 71.3 6 13.3 beats/min (p 5 0.53) (ISP-independent
group versus ISP-dependent group, respectively). In the
ISP-dependent group, continuous infusion of ISP caused a
significant increase in supine HR to 106.2 6 19.7 beats/min
(p , 0.01) and a small increase in supine systolic BP to
139.4 6 16.6 mm Hg (p 5 0.16), and a significant decrease
in supine diastolic BP to 68.6 6 8.0 mm Hg (p , 0.01). At
positive response, ultimate BP was approximately the same
in both groups (mean BP; ISP-independent group, 51.5 6
8.6 mm Hg versus ISP-dependent group, 58.5 6
5.9 mm Hg; p 5 0.06), and ultimate HR was significantly
lower in the ISP-independent group (64.1 6 23.2 beats/
min) than in the ISP-dependent group (97.2 6 16.7
beats/min, p , 0.01).
CAS AND HEMODYNAMICS DURING NEGATIVE HUT ALONE.
Control (without ISP) supine EP levels were similar in both
groups (ISP-independent group, 0.11 6 0.04 ng/ml vs.
ISP-dependent group, 0.07 6 0.03 ng/ml; p 5 0.08).
Control supine NE levels were significantly higher in the
ISP-dependent group (0.22 6 0.07 ng/ml) than in the
ISP-independent group (0.12 6 0.06 ng/ml, p , 0.01).
Blood samples during negative HUT alone were obtained
from nine negative response patients (ISP-dependent
group). In these patients, BP and HR remained at the same
level during the 15-min tilting (Fig. 2,A). EP did not
change significantly (a mean rate of increase at 15 min
tilting, 1.1-fold; baseline vs. at 15 min tilting, p 5 0.36, Fig.
2,B). NE showed a small but statistical increase at 15 min of
tilting (a mean rate of increase at 15 min tilting, 1.7-fold;
baseline vs. at 15 min tilting, p , 0.01, Fig. 2,B).
Outcome of the second step. All 17 patients who had a
positive response in the initial step experienced syncope in
the second step.
HEMODYNAMICS. The time to positive response in the initial
step was similar to that in the second step (Table 1).
Changes in hemodynamics are shown in Figure 3. During
upright posture, HR tended to increase until just before
positive response (until 21 min) in both groups. At positive
response, BP dropped to approximately the same level in
both groups, but the ultimate HR was significantly higher in
the ISP-dependent group than in the ISP-independent
group. Regarding the pattern of sequential hemodynamic
changes, positive HUT resulted in similar hemodynamic
responses in both groups.
CAS DURING POSITIVE HUT ALONE OR WITH ISP. In the
second step, 100 blood samples were to be collected accord-
Table 1. Outcomes of Initial, Second, and Third Steps
Patient Gender Age
Isoproterenol
(mg/kg/min)
Time to Positive Response (minute)
Initial Step Second Step Third Step
1 M 23 0 12.25 12.20 14.25
2 F 28 0 2.00 3.17 5.50
3 F 27 0 6.67 5.00 7.00
4 M 30 0 4.25 7.00 8.25
5 F 16 0 4.75 4.25 ND
6 M 51 0 3.00 2.00 5.00
7 F 28 0 12.00 10.00 ND
8 F 23 0 5.00 5.83 9.40
mean 6 SD 28.3 6 10.2 6.2 6 3.9 6.2 6 3.4 8.3 6 3.4
9 F 49 0.01 6.00 7.50 ND
10 M 43 0.01 2.47 3.75 negative
11 F 57 0.01 4.00 3.50 11.00
12 M 55 0.01 3.33 4.75 negative
13 F 48 0.02 5.50 5.75 negative
14 M 25 0.02 5.00 5.50 12.00
15 F 49 0.02 3.50 3.00 negative
16 F 21 0.02 5.50 4.75 negative
17 F 60 0.02 3.00 4.00 negative
mean 6 SD 45.2 6 13.6 4.3 6 1.3 4.7 6 1.4
p value 5 0.054, ND, not done.
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ing to the predetermined study design. We were not able to
obtain 27 of these blood samples; however, all blood
samples at baseline and at positive response were obtained.
Changes in CAs are shown in Figure 4. Baseline EP levels
tended to be higher in the ISP-independent group than in
the ISP-dependent group (p 5 0.05). In the ISP-
independent group, EP began increasing significantly at
23 min (a mean rate of increase, 4.1-fold) and showed a
maximum increase at positive response (a mean rate of
increase, 11.7-fold; range, 5.2- to 43.6-fold; baseline,
0.11 6 0.04 ng/ml vs. at positive response, 1.29 6
0.90 ng/ml; p , 0.01, Fig. 4,A). In the ISP-dependent
group, EP showed a significant increase at positive response
(a mean rate of increase, 5.0-fold; range, 2.4- to 13.4-fold;
baseline, 0.07 6 0.04 ng/ml vs. at positive response, 0.35 6
0.31 ng/ml; p 5 0.02, Fig. 4,B). The ultimate EP levels
(1.29 6 0.90 ng/ml) in the ISP-independent group was
significantly higher (p 5 0.01) than that (0.35 6
0.31 ng/ml) in the ISP-dependent group. Baseline NE
levels were significantly higher in the ISP-dependent group
(0.34 6 0.15 ng/ml) than in the ISP-independent group
(0.12 6 0.06 ng/ml, p , 0.01). In the ISP-independent
group, NE levels showed a statistical increase at positive
response (a mean rate of increase, 2.5-fold; baseline versus at
positive response, p , 0.01, Fig. 4,C). In the ISP-
dependent group, NE levels showed a small but statistical
increase at positive response (a mean rate of increase,
1.5-fold; baseline vs. at positive response, p 5 0.02, Fig.
4,D).
Outcome of the third step. Among patients in the ISP-
independent group, two patients refused PROP therapy.
The remaining six patients participated in the PROP test.
Although PROP did not interrupt a positive response in any
of the six patients, the time to positive response was
prolonged significantly compared with that of the initial
(p , 0.01) and second steps (p , 0.01, Table 1). In the
ISP-dependent group, eight patients participated in the
third step. After PROP, a positive response did not develop
in six of these eight patients (Table 1). The PROP therapy
was more effective in ISP-dependent group than in ISP-
independent group (p , 0.01).
HEMODYNAMICS. In the ISP-independent group, PROP
significantly decreased supine HR (64.8 6 7.5 to 57.0 6 5.8
beats/min, p , 0.01) and supine systolic BP (125.5 6 8.3 to
117.3 6 12.5 mm Hg, p 5 0.02), but it did not change
supine diastolic BP (67.8 6 9.2 to 73.2 6 8.3 mm Hg, p 5
0.17). In the ISP-dependent group, PROP caused a signif-
icant decrease in supine HR (109.3 6 18.7 to 79.0 6 13.0
beats/min, p , 0.01), a significant increase in supine
diastolic BP (67.9 6 8.3 to 75.0 6 9.3 mm Hg, p , 0.01)
and a small decrease in supine systolic BP (139.4 6 17.7 to
129.5 6 9.6 mm Hg, p 5 0.05). At positive response, BP
Figure 2. Sequential changes in hemodynamic and CAs during
negative tilt testing without ISP. In patients negative for the HUT
alone, mean BP and HR were stable (A). Although EP did not
change statistically, NE showed a small but significant increase
(B). *p , 0.01 when compared with baseline values.
Figure 3. Sequential hemodynamic changes during positive tilt
testing in the second step. HR increased during upright posture,
although not significantly, until just before positive response (until
21 min). HR throughout tilt testing was significantly higher in the
ISP-dependent group than in the ISP-independent group. Mean
BP dropped suddenly to the same level in both groups. The pattern
of sequential changes was similar in both groups. *p , 0.05 when
compared between groups. †p , 0.05 when compared with
baseline values.
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and HR were approximately the same as in the initial and
second steps in each patient.
CAS IN THE ISP-INDEPENDENT GROUP. After PROP, supine
EP levels (0.15 6 0.07 to 0.11 6 0.03 ng/ml, p 5 0.15) and
supine NE levels (0.14 6 0.02 to 0.13 6 0.03 ng/ml, p 5
0.39) did not change. At positive response, EP showed a
significant increase (a mean rate of increase, 20.3-fold;
range, 7.2- to 67.5-fold; baseline vs. at positive response,
p , 0.01, Fig. 5,A), NE showed a small but statistical
increase (a mean rate of increase, 2.6-fold; baseline versus at
positive response, p 5 0.04).
CAS IN THE ISP-DEPENDENT GROUP. After PROP, supine
EP levels did not change significantly (0.12 6 0.12 to
0.07 6 0.05 ng/ml, p 5 0.13) and supine NE levels tended
to decrease (0.31 6 0.18 to 0.21 6 0.07 ng/ml, p 5 0.05).
In the six PROP responders, EP levels showed a small
increase at the end of HUT (a mean rate of increase,
2.2-fold; range, 1.3 to 5.2-fold; baseline versus at the end of
HUT, p 5 0.05, Fig. 5,B) and NE levels showed a small but
statistical increase at the end of HUT (a mean rate of
increase, 1.7-fold; baseline versus at the end of HUT, p 5
0.04). The mean rate of increase for EP at the end of
negative HUT in the third step was significantly greater
than in the negative HUT in the initial step (p 5 0.04). The
two PROP nonresponders (patients 11 and 14) showed a
Figure 4. Sequential changes in CAs during positive HUT alone or with ISP provocation. Baseline EP levels were similar in the two
groups. In the ISP-independent group, EP levels increased gradually during upright posture and showed a significant increase at 23 min
and a maximum increase at positive response (A). In the ISP-dependent group, EP levels increased gradually, and the difference reached
the significance level at positive response (B). In both groups, there was statistical increase in NE levels at positive response (C, D). *p ,
0.05. †p , 0.01.
Figure 5. Changes in EP after PROP. In the ISP independent
group, EP showed a significant increase (A). In the ISP-dependent
group, PROP responders had a mean 2.2-fold increase in EP levels
at 15 min of tilting. Two PROP nonresponders showed a marked
increase (29.2- and 11.7-fold) in EP levels (arrow) (B).
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marked increase (29.2- and 11.7-fold, respectively) in EP
levels (shown by arrow in Fig. 5,B) at positive response.
DISCUSSION
Supine NE. Control (without ISP) supine NE levels were
significantly higher in the ISP-dependent group than in the
ISP-independent group; however, the ISP-dependent
group tended to be older than the ISP-independent group.
Age-related increases in plasma NE levels have been re-
ported among normotensive individuals (11–13); it has been
reported also that plasma EP levels do not change with age
(11,14). In our study, supine NE levels increased signifi-
cantly by continuous ISP infusion and tended to decrease
after PROP. Goldstein et al. (12) reported that intravenous
ISP increases plasma NE levels, probably by augmenting
NE release from sympathetic nerve endings.
Role of NE in HUT. Arterial baroreflexes affecting espe-
cially skeletal muscle sympathoneural vasomotor tone are
the important components in the maintenance of postural
normotension. Skeletal sympathoneural system activity in-
creases instantaneously in response to orthostasis, and
plasma levels of NE double within a few minutes (15). In
our study, small but statistical increases in NE levels
(1.7-fold) at 15 min of negative HUT alone were registered
concomitant with unchanged EP levels. These results are
similar to those of previous studies (16,17), and may suggest
that activation of the sympathoneural system results in
inhibition of the development of NMS. However, a report
of severely reduced cardiac and renal NE spillover in
patients who fainted during cardiac catheterization is in
support of a sudden decrease in cardiac and renal sympa-
thoneural activity during NMS (18). Plasma concentrations
of NE are governed by a balance between the release of NE
from sympathetic nerve endings, reuptake into the endings
and catabolism of the amines (4). The reduction of cardiac
output during NMS may cause a reduction in plasma CA
clearance and lead to an elevation of plasma CA concentra-
tion (19). In the present study, small but statistical increases
in brachial artery NE levels at positive response were
registered. This suggests that an increase in NE release,
rather than a lack of clearance, may be responsible for the
raised concentration in this study.
Triggering Mechanism for NMS. Two different trigger-
ing mechanism for NMS, central and peripheral, have been
proposed (20). The central pathway descends from cortico-
hypothalamic centers to medullary cardiovascular centers:
emotional events can evoke NMS. The peripheral pathway
is postulated to originate from various sites in the cardio-
vascular system. The assumed peripheral mechanism is as
follows: 1) upright posture reduces venous return leading to
a decrease in left ventricular filling pressure, cardiac output
and arterial BP; 2) occasionally, the combination of reduced
left ventricular filling pressure and raised sympathetic tone
results in vigorous ventricular contraction, which can para-
doxically stimulate ventricular mechanoreceptors, thereby 3)
eliciting the Bezold-Jarisch reflex (21). Accordingly, the
raised transient sympathetic tone is thought to be necessary
for development of NMS (2,3). In this study, increasing HR
before positive response was demonstrated in both groups.
This relative tachycardia is thought to indicate raised
transient sympathetic tone.
EP has been suggested as the humoral vasodilator in
NMS (22,23). In addition, EP can enhance the activity of
ventricular mechanoreceptors directly and via vigorous con-
traction (24). When patients developed NMS during HUT
alone, the gradual increases of EP reached significant levels
at 23-min (4.1-fold) and maximum levels at positive
response (11.7-fold). This EP surge may contribute to a
vigorous ventricular contraction, which triggers the Bezold-
Jarisch reflex, as well as dilation in both skeletal muscle and
splanchnic resistance vessels. Calkins et al. (25) compared
the effects of ISP and EP on NMS using HUT. They
showed ISP to be associated with a significantly greater
sensitivity for NMS. They employed continuous adminis-
tration EP (maximum dose 5 100 ng/kg/min) because they
estimated that EP (100 ng/kg/min) infusion results in
systemic levels of 0.484 6 0.0069 ng/ml (26). The present
study demonstrated that the peak EP surge in the brachial
artery was 1.29 6 0.90 ng/ml in the ISP-independent group
and 0.35 6 0.31 ng/ml in the ISP-dependent group. It
follows from this that the dose of EP infused by Calkins et
al. (25) may have been too low to induce NMS. In addition,
continuous infusion may not be suitable. Because the surge
of EP may occur after taking a upright position (Fig. 4,A
and B), nearly bolus injections are thought to be better than
low-dose continuous administration.
Use of ISP. Many investigators have found ISP to be
useful in increasing the susceptibility to NMS during HUT
(3,27), probably for the following reasons. Nonselective
beta-agonist, ISP, has positive inotropic action, which may
augment the cardiac mechanoreceptors, as well as positive
vasodilation action. In the present study, ISP significantly
increased HR and decreased diastolic BP. At positive
response, the increase in EP levels in the ISP-independent
group was significantly higher (p 5 0.01) than that in the
ISP-dependent group. In other words, when patients de-
veloped NMS during HUT plus ISP provocation, a small
increase in EP levels was observed. The comparatively low
EP surge may have been enough to induce NMS during
HUT plus ISP provocation compared with HUT alone,
since exogenous ISP can raise basal sympathetic tone.
Responses to PROP. In ISP-independent patients,
PROP could not prevent NMS. Although the statistical
difference was not significant (p 5 0.06), these patients had
greater ultimate increases (a mean rate of increase, 20.3-
fold) in EP levels at positive response in the third step than
in the second step (a mean rate of increase, 11.7-fold). The
reason for this may be that PROP can attenuate the effects
of released EP but not the release itself. In positive patients,
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the levels of released EP may be strongly dependent on the
tilting time, because the time to positive response was
prolonged significantly compared with that of second step
(p , 0.01).
In the ISP-dependent group, two PROP nonresponders
showed a marked increase in EP levels (29.2- and 11.7-
fold). Even with PROP pretreatment, when EP surges in an
amount sufficient to act as a stimulus for NMS, the NMS
may occur. PROP responders in the ISP-dependent group
had higher levels of EP (2.2-fold) at the end of 15-min
HUT compared with negative HUT in the initial step
(1.1-fold, p 5 0.01). It is likely that the effects of these
2.2-fold EP levels (0.13 6 0.09 ng/ml) are almost dimin-
ished by 0.1 mg/kg of PROP. In these circumstances, if
patients are maintained in the tilting position over 15 min,
some will develop a positive response.
Aging effects. Nearly every aspect of the autonomic system
maintenance of BP can be altered with age (28). Other
investigators reported that patients showing NMS during
HUT alone were younger than patients needing ISP for
NMS (3,29). Newman et al. (11) reported that EP levels
tended to rise with HUT in their younger healthy volunteers
but not in their elderly healthy volunteers. Our ISP-
dependent patients were older than our ISP-independent
patients; the difference did not reach the significance level
(p 5 0.05). This difference in age between the two groups
is thought to play a role in the differences in endogenous
CAs between the two groups, but the difference in age was
a result of our study. If we investigated a large number of
patients, similar results could be observed.
Conclusions. An EP surge may be a triggering mechanism
for NMS. Comparatively low levels of EP are thought to be
enough to induce NMS during tilting with ISP compared
with tilting alone because exogenous ISP can raise basal
sympathetic tone. PROP frequently inhibits NMS, which is
dependent on ISP, but it is not effective in inhibiting NMS,
which is independent of ISP. It is presumed that PROP
(0.1 mg/kg) is insufficient to block the actions of these high
levels of circulating EP.
Study limitations. Our measurement of the plasma CA
levels in the brachial artery is influenced by many organs.
Likewise, direct measurement of peripheral muscle sympa-
thetic bursts is useful to evaluate the sympathoneural activity
(30). Although we concluded that PROP failed to block
NMS that is independent of ISP, further study using a
higher dose of PROP is needed to strengthen this conclu-
sion.
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